Despite being at an increased risk for HIV and hepatitis C, persons who inject drugs (PWID) are tested at dismal rates for both: just 8.6% and 7.7%, respectively, according to data from 2010 to 2017.

Assoumou is an infectious diseases physician-scientist at Boston Medical Center. Miller is a research data associate within Dr. Assoumou’s I-CARE (Infectious Complications Assessment and Research) lab ...

VANCOUVER, B.C., CANADA " March. 23, 2010 - Core Security Technologies, provider of CORE IMPACT Pro, the most comprehensive product for proactive enterprise security testing, today announced that one ...